Stimulatory and inhibitory effects of interleukin (il)-4 and id13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for id12 and tumor necrosis factor α production

Journal of Experimental Medicine

Volumn 181, Issue 2, 1995, Pages 537-546

  D’Andrea, Annalisa ^a,b   Ma, Xiaojing ^a   Aste Amezaga, Miguel ^a   Paganin, Carla ^a   Trinchieri, Giorgio ^a  

^a WISTAR INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CYTOTOXICITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMAL; CELL LINE; CHO CELLS; HAMSTERS; HUMAN; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-4; KINETICS; LEUKOCYTES, MONONUCLEAR; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

EID: 0028911482     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.2.537     Document Type: Article

References (54)

1. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.
2. D’Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nick-barg, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
3. D’Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-7-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp Med. 178: 1041-1048.
4. Murphy, E.E., G. Terres, S.E. Macatonia, CtS. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O’Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon 7 production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp Med. 180: 223-231.
5. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. j. Exp Med. 180: 211-222.
6. Manetti, R., P. Parronchi, M.G. Giudizi, MrP. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp Med. 177: 1199-1204.
7. Hsieh, C., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O’Garra, and K.M. Murphy. 1993. Listeria-induced Thl development in aβ-TCR transgenic CD4+ T cells occurs through macrophage production of IL-12. Science (Wash. DC). 260: 547-549.
8. Germann, T., M.K. Gately, D.S. Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Thl) but not on Th2 cells. Eur. J. Immunol 23: 1762-1770.
9. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. j. Immunol. 146: 3074-3081.
10. Gubler, U., A.O. Chua, D.S. Schoenhaut, C.M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A.G. Wolitzky, P.M. Quinn, P.C. Familletti, et al. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA. 88: 4143-4147.
11. Stern, A.S., F.J. Podlaski, J.D. Hulmes, Y.E. Pan, P.M. Quinn, A.G. Wolitzky, P.C. Familletti, D.L. Stremlo, T. Truitt, R. Chizzonite, et al. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl. Acad. Sci. USA. 87: 6808-6812.
12. Nathan, C.F., H.W. Murray, M.E. Wiebe, and B.Y. Rubin. 1983. Identification of interferon-7 as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
13. Kubin, M., J.M. Chow, and G. Trinchieri. 1993. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-a, and IL-1/3 production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood. 83: 1847-1855.
14. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor /3, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685: 713-739.
15. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood. 81: 2964-2971.
16. de Waal Malefyt, R., H. Yssel, and J.E. de Vries. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150: 4754-4765.
17. Hsu, D., K.W. Moore, and H. Spits. 1992. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-y synthesis and lymphokine-activated killer activity. Int. Immunol. 4: 563-569.
18. Minty, A., P. Chalon, J. Derocq, X. Dumont, J. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature (Lond.). 362: 248-250.
19. McKenzie, A.N.J., J.A. Culpepper, R. de Waal Malefyt, F. Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B.G. Cocks, S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl. Acad. Sci. USA. 90: 3735-3739.
20. Zurawski, G., and J.E. de Vries. 1994. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today. 15: 19-26.
21. de Waal Malefyt, R., C.G. Figdor, and J.E. de Vries. 1993. Effects of interleukin-4 on monocyte functions: comparison to interleukin-13. Res. Immunol. 144: 629-633.
22. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor. J. Exp. Med. 179: 1109-1118.
23. Peters, J.H., J. Ruppert, R.K. Giesler, H.M. Najar, and H. Xu. 1991. Differentiation of human monocytes into CD14 negative accessory cells: do dendritic cells derive from the monocytic lineage? Pathobiology. 59: 122-126.
24. Vercelli, D., H.H. Jabara, BW. Lee, N. Woodland, R.S. Geha, and D.Y.M. Leung. 1988. Human recombinant interleukin 4 induces FceR2/CD23 on normal human monocytes. J. Exp. Med. 167: 1406-1416.
25. Te Velde, A.A., F. Rousset, C. Peronne, J.E. de Vries, and C.G. Figdor. 1990. IFN-a and IFN-y have different regulatory effects on IL-4 induced membrane expression of FceRIIb and release of soluble FceRIIb by human monocytes. J. Immunol. 144: 3052-3059.
26. Te Velde, A.A., J.P.G. Klomp, B.A. Yard, J.E. de Vries, and C.G. Figdor. 1988. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 140: 1548-1554.
27. Becker, S., and E.G. Daniel. 1990. Antagonistic and additive effects of IL-4 and IFNy on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell. Immunol. 129: 351-362.
28. Littman, B.H., F.F. Dastvan, P.L. Carlson, and K.M. Sanders. 1989. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFNy. J. Immunol. 142: 520-525.
29. Gerrard, T.L., D.R. Dyer, and H.S. Mostowski. 1990. IL-4 and granulocyte-macrophage colony stimulating factor selectively increase HLA-DR and HLA-DP antigens, but not HLA-DQ antigens on human monocytes. J. Immunol. 144: 4670-4674.
30. de Waal Malefyt, R., C.G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J.E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol. 151: 6370-6381.
31. Donnelly, R.P., M.J. Fenton, J.D. Kaufman, and T.L. Gerrard. 1991. IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J. Immunol. 146: 3431-3436.
32. Hart, P.H., G.F, Vitti, D.R. Burgess, G.A. Whitty, D.S. Pic-coli, and J.A. Hamilton. 1989. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor a, interleukin 1 and prostaglandin E2. Proc. Natl. Acad. Sci. USA. 86: 3803-3087.
33. Essner, R., K. Rhoades, W.H. McBride, D.L. Morton, and J.S. Economou. 1989. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142: 3857-3861.
34. Te Velde, A. A., R.J.F. Huijbens, J.E. de Vries, and C.G. Figdor. 1990. Interleukin 4 inhibits secretion of IL-1/3, tumor necrosis factor a, and IL-6 by human monocytes. Blood. 76: 1392-1397.
35. Hamilton, J.A., G.A. Whitty, A.K.M. Royston, J. Cebon, and J.E. Layton. 1992. Interleukin 4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes. Immunology. 76: 566-571.
36. Wieser, M., R. Bonifer, W. Oster, A. Lindemann, R. Mer-telsmann, and F. Herrmann. 1989. Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes. Blood. 73: 1105-1108.
37. Suk, K., S.D. Somers, and K.L. Erickson. 1993. Regulation of murine macrophage function by IL-4: IL-4 and IFN-y differentially regulate macrophage tumoricidal activation. Immunology. 80: 617-624.
38. Stenger, S., W. Solbach, M. Rollinghoff, and C. Bogdan. 1991. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL)-4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL-4. Eur. J. Immunol. 21: 1669-1675.
39. Molina, I.J., and B.T. Huber. 1991. Regulation of macrophage activation markers by IL-4 and IFN-y is subpopulation-specific. Cell. Immunol. 134: 241-248.
40. Phillips, W.A., M. Croatto, and J.A. Hamilton. 1992. The effect of interleukin-4 on the macrophage respiratory burst is species dependent. Biochem. Biophys. Res. Commun. 182: 727-732.
41. Fontaine, S., C. Damais, D. Lando, and M.A. Cousin. 1989. Monoclonal antibodies to human interleukin-1 beta and their use in a sensitive two-site enzyme linked immunosorbent assay. Lymphokine Res. 8: 129-139.
42. Murphy, M., R. Loudon, M. Kobayashi, and G. Trinchieri. 1986. y interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation. J. Exp. Med. 164: 263-279.
43. Cuturi, M.C., M. Murphy, M.P. Costa-Giomi, R. Weinmann, B. Perussia, and G. Trinchieri. 1987. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med. 165: 1581-1594.
44. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trin-chieri. 1991. Induction of interferon 7 production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp Med. 173: 869-879.
45. Chan, S.H., M. Kobayashi, D. Santoli, B. Perussia, and G. Trin-chieri. 1992. Mechanisms of IFN-7 induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148: 92-98.
46. Cassatella, M.A., L. Hartman, B. Perussia, and G. Trinchieri. 1989. Tumor necrosis factor and immune interferon synergisti-cally induce cytochrome b_245 heavy chain gene expression and NADPH oxidase in human leukemic myeloid cells. J. Clin. Invest. 83: 1570-1579.
47. Cassatella, M.A., L. Meda, S. Gasperini, A. D’Andrea, X. Ma, and G. Trinchieri. 1994. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. In press.
48. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of ThI cells. Immunol. Today. 14: 335-338.
49. Trinchieri, G. 1995. Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions which bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13: 251-276.
50. Nagler, A., L.L. Lanier, and J.H. Phillips. 1988. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. j. Immunol. 141: 2349-2351.
51. Wu, C.Y., C.E. Demeure, M. Gately, F. Podlaski, H. Yssel, M. Kiniwa, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152: 1141-1153.
52. Finkelman, F.D., K.B. Madden, A.W. Cheever, I.M. Katona, S.C. Morris, M.K. Gately, B.R. Hubbard, W.C. Gause, and J.F. Urban, Jr. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179: 1563-1572.
53. Zlotnik, A., M. Fischer, N. Roehm, and D. Zipori. 1987. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages. j. Immunol. 138: 4275-4279.
54. Aiello, F.B., D.L. Longo, R. Overton, L. Takacs, and S.K. Durum. 1990. A role for cytokines in antigen presentation: IL-1 and IL-4 induce accessory functions of antigen-presenting cells. J. Immunol. 144: 2572-2581.